Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employeeswho bringdifferent and innovativeways of seeing the world and solving problems.Fred Hutch is in pursuit of becoming an antiracist organization.Weare committed to ensuring that all candidates hired share our commitment to diversity,antiracism, and inclusion.
The Clinical Research Technologist I performs a variety of hematological, microbiologic, immunologic, chemical and other tests related to diagnosis, treatment, and post-treatment follow-up of disease or uses similar techniques to monitor study participants. Involves operating analytical instruments; recovering, compiling, and verifying the accuracy of clinical data; performing calculations; preparing charts, graphs, and summaries.
They work under the direction of Supervisor or higher-level laboratory personnel. Uses limited judgment and discretion in carrying out procedures.
Perform standardized clinical/diagnostic tests at bench level.
Interpret and report on test results.
Log in, record, process, and track clinical specimens.
Prepare specimens for long term storage by methods such as cryopreservation, fixed slides.
Prepare and maintain laboratory reagents, stocks.
Perform documented protocols and assays.
Maintain laboratory records, compute data, and enter onto computer database.
Operate and carry out basic maintenance of lab equipment.
Order and maintain appropriate level of lab supplies.
May supervise work-study students.
Perform other duties as required.
Molecular Oncology Specific Duties
Maintain consistently high-performance standards and quality of work.
Adheres to internal SOPs and applicable regulatory requirements.
May participate in regulatory inspections, third party client audits as assigned including monitoring and implementing corrective action activities.
Is involved in document control system, including maintenance of internal procedures, and ensuring that document change requests and biennial reviews of documents are facilitated and implemented within a timely manner.
Perform molecular clinical testing in a compliance with state and federal standards and regulations (DOH,CLIA,CAP). Includes sample processing, extracting nucleic acid, RT-PCR/PCR and target detection. Both moderate and high complexity testing involved.
Basic understanding of next generation sequencing technology.
Knowledge of lab safety and sterile techniques.
Should be willing to work on weekends.
Bachelors degree in Science.
One-year experience as a Laboratory Tech I or equivalent is preferred.
Molecular Oncology Specific Qualification
Bachelors degree in field of Laboratory Science or equivalent.
Certified by the American Society of Clinical Pathologists (ASCP) as a Medical Laboratory Technologist (MLT) would be preferred.
Proficient Molecular laboratory skills and strong scientific knowledge in study required.
Must be detailed oriented with ability to maintain accurate digital and paper records.
Strong organizational and multi-tasking skills are required as are excellent verbal and written communication skills.
Proficiency in MS office applications is essential.
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations. As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.